Addressing Clinical Inertia in the Initiation and Management of Insulin Therapy: Quality Improvement Strategies for Primary Care

This online CME program addresses important strategies for achieving early and intensive management through individualized care, avoiding adverse events, improving onset and bioavailability, improving access, and reducing nonadherence. The program will include critical up-to-date position statements from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).


Jaime A Davidson, M.D., FACP, MACE

Clinical Professor of Medicine
Touchstone Diabetes Center
Division of Endocrinology, Diabetes and Metabolism
The University of Texas Southwestern Medical Center
Dallas, Texas

Shane Greene, Pharm.D., BCPS
Associate Professor-Ambulatory Care
Department of Pharmacy Practice
Texas Tech University Health Sciences Center School of Pharmacy
Dallas, Texas

Catherine Hill, DNP, APRN, GNP-BC
Director of Quality and Clinical Outcomes
Texas Health Resources, Texas Health Physicians Group
Euless, Texas

Louis Kuritzky, M.D.
Family Physician
Clinical Assistant Professor
Department of Community Health and Family Medicine
University of Florida
Gainesville, Florida

Program Topics

Current Situation/Inertia Problems - Kuritzky
Individualized Care - Davidson
Adverse Events - Kuritzky
Improving Onset - Davidson
Access - Hill
Nonadherence - Greene
Panel - Questions & Answers

Program Objectives

As a result of this program, the participants should be able to:

  • Evaluate changes in provider interventions in diabetes management
  • Evaluate determinants of insulin initiation and intensification
  • Promote individualized treatment plans in T2DM
  • Apply current evidence when using pharmacologic treatment in patients with T2DM
  • Explain the benefits and limitations of currently available agents
  • Implement new pharmacologic strategies to reach HbA1C goals
  • Identify barriers and implement strategies for overcoming those barriers to provide optimal care and improve patient outcomes


Texas Health Research & Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Texas Health Research & Education Institute designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For Additional Information
Call 866-295-3269

Click here

Share this page!